{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:20:24Z","timestamp":1785205224724,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.oret.2025.02.030","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T12:06:27Z","timestamp":1742558787000},"page":"860-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Clinical Features of Polypoidal Choroidal Vasculopathy in Black Patients"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1318-649X","authenticated-orcid":false,"given":"Adam","family":"Lazrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0166-0513","authenticated-orcid":false,"given":"Martin","family":"Bonnafous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Jean-Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Ouamrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliz\u00e9e","family":"Tabouillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanice","family":"Chaoui-Boudghane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.02.030_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9394(85)90682-8","article-title":"Multiple recurrent serosanguineous retinal pigment epithelial detachments in Black women","volume":"100","author":"Stern","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.eye.6700706","article-title":"Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population","volume":"18","author":"Ladas","year":"2004","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2025.02.030_bib4","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1111\/aos.12110","article-title":"Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types","volume":"91","author":"Kawamura","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ajo.2013.07.001","article-title":"Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy","volume":"156","author":"Cho","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000002583","article-title":"Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy","volume":"40","author":"Chang","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/23258160-20231113-01","article-title":"Racial differences in choroidal vascularity index in healthy patients: novel insights","volume":"55","author":"Moir","year":"2024","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib8","series-title":"Migrations, Famille et Vieillissement en Martinique: Premiers r\u00e9sultats de l\u2019enqu\u00eate MFV-2","author":"Marie","year":"2024"},{"key":"10.1016\/j.oret.2025.02.030_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archophthalmol.2007.53","article-title":"Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project","volume":"126","author":"Bressler","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy","volume":"99","author":"Tan","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/IAE.0000000000000482","article-title":"Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified Everest criteria","volume":"35","author":"Cheung","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1001\/jama.2022.9083","article-title":"The imperative for diversity and inclusion in clinical trials and health research participation","volume":"327","author":"Bibbins-Domingo","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.02.030_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.02.030_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00417-010-1575-7","article-title":"Clinical characteristics of polypoidal choroidal vasculopathy in Chinese patients","volume":"249","author":"Hou","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/bjophthalmol-2013-303444","article-title":"Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response","volume":"98","author":"Hatz","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib20","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","article-title":"Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration","volume":"56","author":"Coscas","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.02.030_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40942-017-0060-4","article-title":"Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom","volume":"3","author":"Alasil","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2025.02.030_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/OPTH.S126226","article-title":"Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization","volume":"11","author":"Bhoomibunchoo","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/1120672119874674","article-title":"Idiopathic polypoidal choroidal vasculopathy in Caucasians: the POLYON real-life study in 50 naive patients","volume":"30","author":"El Chehab","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4103871","article-title":"Polypoidal choroidal vasculopathy in Congolese patients","volume":"2020","author":"Kabedi","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000503834","article-title":"Clinical characteristics of polypoidal choroidal vasculopathy and anti-vascular endothelial growth factor treatment response in Caucasians","volume":"243","author":"Kokame","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2025.02.030_bib28","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/bjophthalmol-2020-317537","article-title":"T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy","volume":"105","author":"Jordan-Yu","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib29","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jfo.2021.06.012","article-title":"Effect of intravitreal injection of bevacizumab in treated and untreated eyes of Black African patients with polypoidal choroidal vasculopathy","volume":"44","author":"Kabedi","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000515295","article-title":"Polypoidal choroidal vasculopathy in Caucasians: morphological findings from multimodal retinal imaging","volume":"244","author":"Sim\u00e3o","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2025.02.030_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00417-020-04844-z","article-title":"The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification","volume":"259","author":"van Dijk","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ajo.2021.08.006","article-title":"Multimodal imaging comparison of polypoidal choroidal vasculopathy between Asian and Caucasian populations","volume":"234","author":"Corvi","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12886-022-02551-3","article-title":"Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy","volume":"22","author":"Yap","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40942-022-00432-x","article-title":"Polypoidal choroidal vasculopathy\u2014characteristics and response to treatment with bevacizumab in Caucasian patients","volume":"8","author":"Zhalka","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2025.02.030_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ceo.14305","article-title":"Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians","volume":"51","author":"Airaldi","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib36","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41598-023-31649-x","article-title":"Clinical variations of polypoidal choroidal vasculopathy: a cohort study from Japan and the USA","volume":"13","author":"Fukuyama","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.02.030_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","article-title":"Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients","volume":"52","author":"Byeon","year":"2008","journal-title":"Jpn J Ophthalmol"},{"issue":"6 Pt 1","key":"10.1016\/j.oret.2025.02.030_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0181-5512(08)75458-5","article-title":"Polypoidal choroidal vasculopathy: clinical and angiographic features","volume":"31","author":"Guyomarch","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ceo.13114","article-title":"Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u2018expanded spectra\u2019 \u2013 a review","volume":"46","author":"Dansingani","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/IAE.0000000000003666","article-title":"Five-year incidence of fellow eye neovascular involvement in age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population","volume":"43","author":"Teo","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib39","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","article-title":"The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients","volume":"253","author":"Cheung","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib40","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1111\/j.1755-3768.2009.01850.x","article-title":"Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes","volume":"88","author":"Okubo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib41","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1111\/aos.14676","article-title":"Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration","volume":"99","author":"Cho","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib42","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ophtha.2003.08.042","article-title":"Five-year incidence of age-related maculopathy: the Visual Impairment Project","volume":"111","author":"Mukesh","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.030_bib43","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.3390\/jcm11164766","article-title":"European prevalence of polypoidal choroidal vasculopathy: a systematic review, meta-analysis, and forecasting study","volume":"11","author":"van Dijk","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.oret.2025.02.030_bib44","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ophtha.2014.06.016","article-title":"Polypoidal choroidal vasculopathy in adult Chinese: the Beijing Eye Study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.030_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2018.1506483","article-title":"Prevalence and risk factors for polypoidal choroidal vasculopathy in a general Japanese population: the Hisayama study","volume":"33","author":"Fujiwara","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/APO.0000000000000573","article-title":"Polypoidal choroidal vasculopathy: updates on risk factors, diagnosis, and treatments","volume":"12","author":"Ruamviboonsuk","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.oret.2025.02.030_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/IAE.0b013e31802be7a3","article-title":"Familial bilateral polypoidal choroidal vasculopathy","volume":"2","author":"Merle","year":"2008","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2025.02.030_bib48","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1167\/iovs.16-20175","article-title":"Association of ABCG1 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese and Japanese","volume":"57","author":"Ma","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.02.030_bib49","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bjophthalmol-2019-315746","article-title":"Identification of TIE2 as a susceptibility gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"105","author":"Chen","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib50","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/eye.2014.226","article-title":"FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"28","author":"Liang","year":"2014","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2025.02.030_bib51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/jhg.2017.83","article-title":"Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians","volume":"62","author":"Fan","year":"2017","journal-title":"J Hum Genet"},{"key":"10.1016\/j.oret.2025.02.030_bib52","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ophtha.2015.05.012","article-title":"Association of genetic variants with polypoidal choroidal vasculopathy: a systematic review and updated meta-analysis","volume":"122","author":"Ma","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.030_bib53","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/OPTH.S337084","article-title":"Class II human leukocyte antigen (HLA) and susceptibility to polypoidal choroidal vasculopathy in Afro-Caribbean descent","volume":"16","author":"Merle","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bjophthalmol-2016-309144","article-title":"Short-term efficacy of intravitreal aflibercept depending on angiographic classification of polypoidal choroidal vasculopathy","volume":"101","author":"Jeong","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib55","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IAE.0000000000001776","article-title":"Comparison of optical coherence tomography angiographic changes after anti\u2013vascular endothelial growth factor therapy alone or in combination with photodynamic therapy in polypoidal choroidal vasculopathy","volume":"38","author":"Teo","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.02.030_bib56","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajo.2010.10.030","article-title":"Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy","volume":"151","author":"Maruko","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib57","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1038\/s41598-020-65346-w","article-title":"Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy","volume":"10","author":"Azuma","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.02.030_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00417-002-0459-x","article-title":"Polypoidal choroidal vasculopathy with large vascular network","volume":"240","author":"Tateiwa","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.02.030_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s40135-019-00201-4","article-title":"Polypoidal choroidal vasculopathy","volume":"7","author":"Goldhardt","year":"2019","journal-title":"Curr Ophthalmol Rep"},{"key":"10.1016\/j.oret.2025.02.030_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.02.030_bib61","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s40123-024-00952-9","article-title":"Perspectives and update on the global shortage of verteporfin (Visudyne\u00ae)","volume":"13","author":"Sirks","year":"2024","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:51:21Z","timestamp":1768312281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2468653025001149"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.02.030","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Clinical Features of Polypoidal Choroidal Vasculopathy in Black Patients","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}